nodes	percent_of_prediction	percent_of_DWPC	metapath
Felbamate—L-Phenylalanine—Melphalan—ovarian cancer	0.673	1	CrCrCtD
Felbamate—GRIN2B—ErbB4 signaling events—YAP1—ovarian cancer	0.00037	0.0392	CbGpPWpGaD
Felbamate—GRIN2B—ErbB4 signaling events—EREG—ovarian cancer	0.000345	0.0365	CbGpPWpGaD
Felbamate—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—ovarian cancer	0.000267	0.0283	CbGpPWpGaD
Felbamate—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NSF—ovarian cancer	0.000252	0.0267	CbGpPWpGaD
Felbamate—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—ovarian cancer	0.000243	0.0257	CbGpPWpGaD
Felbamate—Dysphagia—Epirubicin—ovarian cancer	0.000215	0.000678	CcSEcCtD
Felbamate—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NSF—ovarian cancer	0.000214	0.0227	CbGpPWpGaD
Felbamate—Dehydration—Doxorubicin—ovarian cancer	0.000214	0.000675	CcSEcCtD
Felbamate—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000214	0.000674	CcSEcCtD
Felbamate—Oedema—Paclitaxel—ovarian cancer	0.000214	0.000674	CcSEcCtD
Felbamate—Eosinophilia—Epirubicin—ovarian cancer	0.000213	0.000671	CcSEcCtD
Felbamate—Infection—Paclitaxel—ovarian cancer	0.000212	0.00067	CcSEcCtD
Felbamate—Pancreatitis—Epirubicin—ovarian cancer	0.000211	0.000664	CcSEcCtD
Felbamate—Dizziness—Vinorelbine—ovarian cancer	0.00021	0.000663	CcSEcCtD
Felbamate—GRIN2B—BDNF signaling pathway—NSF—ovarian cancer	0.000209	0.0222	CbGpPWpGaD
Felbamate—Hypokalaemia—Doxorubicin—ovarian cancer	0.000209	0.00066	CcSEcCtD
Felbamate—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000209	0.00066	CcSEcCtD
Felbamate—Tachycardia—Paclitaxel—ovarian cancer	0.000209	0.000658	CcSEcCtD
Felbamate—Aspartate aminotransferase increased—Doxorubicin—ovarian cancer	0.000207	0.000653	CcSEcCtD
Felbamate—Toxic epidermal necrolysis—Doxorubicin—ovarian cancer	0.000207	0.000653	CcSEcCtD
Felbamate—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000207	0.000652	CcSEcCtD
Felbamate—Anaemia—Docetaxel—ovarian cancer	0.000205	0.000647	CcSEcCtD
Felbamate—Pancytopenia—Epirubicin—ovarian cancer	0.000204	0.000644	CcSEcCtD
Felbamate—Anorexia—Paclitaxel—ovarian cancer	0.000204	0.000642	CcSEcCtD
Felbamate—Gastritis—Doxorubicin—ovarian cancer	0.000204	0.000642	CcSEcCtD
Felbamate—Alanine aminotransferase increased—Doxorubicin—ovarian cancer	0.000203	0.00064	CcSEcCtD
Felbamate—Muscular weakness—Doxorubicin—ovarian cancer	0.000203	0.00064	CcSEcCtD
Felbamate—Vomiting—Vinorelbine—ovarian cancer	0.000202	0.000637	CcSEcCtD
Felbamate—Dysuria—Epirubicin—ovarian cancer	0.000201	0.000634	CcSEcCtD
Felbamate—Rash—Vinorelbine—ovarian cancer	0.0002	0.000632	CcSEcCtD
Felbamate—Dermatitis—Vinorelbine—ovarian cancer	0.0002	0.000631	CcSEcCtD
Felbamate—Hypotension—Paclitaxel—ovarian cancer	0.0002	0.00063	CcSEcCtD
Felbamate—Upper respiratory tract infection—Epirubicin—ovarian cancer	0.0002	0.00063	CcSEcCtD
Felbamate—Headache—Vinorelbine—ovarian cancer	0.000199	0.000628	CcSEcCtD
Felbamate—Dysphagia—Doxorubicin—ovarian cancer	0.000199	0.000627	CcSEcCtD
Felbamate—Asthma—Doxorubicin—ovarian cancer	0.000199	0.000627	CcSEcCtD
Felbamate—Leukopenia—Docetaxel—ovarian cancer	0.000199	0.000627	CcSEcCtD
Felbamate—Eosinophilia—Doxorubicin—ovarian cancer	0.000197	0.000621	CcSEcCtD
Felbamate—Palpitations—Docetaxel—ovarian cancer	0.000196	0.000619	CcSEcCtD
Felbamate—Photosensitivity reaction—Epirubicin—ovarian cancer	0.000196	0.000619	CcSEcCtD
Felbamate—Weight increased—Epirubicin—ovarian cancer	0.000196	0.000617	CcSEcCtD
Felbamate—Pancreatitis—Doxorubicin—ovarian cancer	0.000195	0.000615	CcSEcCtD
Felbamate—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000195	0.000614	CcSEcCtD
Felbamate—Weight decreased—Epirubicin—ovarian cancer	0.000194	0.000613	CcSEcCtD
Felbamate—Hyperglycaemia—Epirubicin—ovarian cancer	0.000194	0.000611	CcSEcCtD
Felbamate—Cough—Docetaxel—ovarian cancer	0.000194	0.000611	CcSEcCtD
Felbamate—Insomnia—Paclitaxel—ovarian cancer	0.000193	0.00061	CcSEcCtD
Felbamate—Pneumonia—Epirubicin—ovarian cancer	0.000193	0.000608	CcSEcCtD
Felbamate—Paraesthesia—Paclitaxel—ovarian cancer	0.000192	0.000605	CcSEcCtD
Felbamate—Hypertension—Docetaxel—ovarian cancer	0.000192	0.000604	CcSEcCtD
Felbamate—Dyspnoea—Paclitaxel—ovarian cancer	0.000191	0.000601	CcSEcCtD
Felbamate—Somnolence—Paclitaxel—ovarian cancer	0.00019	0.000599	CcSEcCtD
Felbamate—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.00019	0.000599	CcSEcCtD
Felbamate—GRIN2A—Transmission across Chemical Synapses—NSF—ovarian cancer	0.000189	0.02	CbGpPWpGaD
Felbamate—Arthralgia—Docetaxel—ovarian cancer	0.000189	0.000596	CcSEcCtD
Felbamate—Chest pain—Docetaxel—ovarian cancer	0.000189	0.000596	CcSEcCtD
Felbamate—Myalgia—Docetaxel—ovarian cancer	0.000189	0.000596	CcSEcCtD
Felbamate—Pancytopenia—Doxorubicin—ovarian cancer	0.000189	0.000595	CcSEcCtD
Felbamate—Nausea—Vinorelbine—ovarian cancer	0.000189	0.000595	CcSEcCtD
Felbamate—Dyspepsia—Paclitaxel—ovarian cancer	0.000188	0.000593	CcSEcCtD
Felbamate—Jaundice—Epirubicin—ovarian cancer	0.000187	0.000589	CcSEcCtD
Felbamate—Conjunctivitis—Epirubicin—ovarian cancer	0.000186	0.000587	CcSEcCtD
Felbamate—Urinary tract infection—Epirubicin—ovarian cancer	0.000186	0.000587	CcSEcCtD
Felbamate—Dysuria—Doxorubicin—ovarian cancer	0.000186	0.000586	CcSEcCtD
Felbamate—Decreased appetite—Paclitaxel—ovarian cancer	0.000186	0.000586	CcSEcCtD
Felbamate—Dry mouth—Docetaxel—ovarian cancer	0.000185	0.000583	CcSEcCtD
Felbamate—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.000185	0.000583	CcSEcCtD
Felbamate—Fatigue—Paclitaxel—ovarian cancer	0.000184	0.000581	CcSEcCtD
Felbamate—Sweating—Epirubicin—ovarian cancer	0.000184	0.000579	CcSEcCtD
Felbamate—Constipation—Paclitaxel—ovarian cancer	0.000183	0.000576	CcSEcCtD
Felbamate—Pain—Paclitaxel—ovarian cancer	0.000183	0.000576	CcSEcCtD
Felbamate—Haematuria—Epirubicin—ovarian cancer	0.000183	0.000576	CcSEcCtD
Felbamate—Confusional state—Docetaxel—ovarian cancer	0.000183	0.000576	CcSEcCtD
Felbamate—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000182	0.000572	CcSEcCtD
Felbamate—Oedema—Docetaxel—ovarian cancer	0.000181	0.000571	CcSEcCtD
Felbamate—Anaphylactic shock—Docetaxel—ovarian cancer	0.000181	0.000571	CcSEcCtD
Felbamate—Weight increased—Doxorubicin—ovarian cancer	0.000181	0.000571	CcSEcCtD
Felbamate—Epistaxis—Epirubicin—ovarian cancer	0.000181	0.00057	CcSEcCtD
Felbamate—Infection—Docetaxel—ovarian cancer	0.00018	0.000568	CcSEcCtD
Felbamate—Weight decreased—Doxorubicin—ovarian cancer	0.00018	0.000567	CcSEcCtD
Felbamate—Sinusitis—Epirubicin—ovarian cancer	0.00018	0.000567	CcSEcCtD
Felbamate—Hyperglycaemia—Doxorubicin—ovarian cancer	0.000179	0.000566	CcSEcCtD
Felbamate—Agranulocytosis—Epirubicin—ovarian cancer	0.000179	0.000564	CcSEcCtD
Felbamate—Pneumonia—Doxorubicin—ovarian cancer	0.000178	0.000562	CcSEcCtD
Felbamate—Thrombocytopenia—Docetaxel—ovarian cancer	0.000177	0.000559	CcSEcCtD
Felbamate—Tachycardia—Docetaxel—ovarian cancer	0.000177	0.000558	CcSEcCtD
Felbamate—Feeling abnormal—Paclitaxel—ovarian cancer	0.000176	0.000555	CcSEcCtD
Felbamate—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.000176	0.000554	CcSEcCtD
Felbamate—Bradycardia—Epirubicin—ovarian cancer	0.000175	0.000552	CcSEcCtD
Felbamate—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000175	0.000551	CcSEcCtD
Felbamate—Haemoglobin—Epirubicin—ovarian cancer	0.000173	0.000545	CcSEcCtD
Felbamate—Jaundice—Doxorubicin—ovarian cancer	0.000173	0.000545	CcSEcCtD
Felbamate—Anorexia—Docetaxel—ovarian cancer	0.000173	0.000545	CcSEcCtD
Felbamate—Rhinitis—Epirubicin—ovarian cancer	0.000172	0.000544	CcSEcCtD
Felbamate—Conjunctivitis—Doxorubicin—ovarian cancer	0.000172	0.000543	CcSEcCtD
Felbamate—Urinary tract infection—Doxorubicin—ovarian cancer	0.000172	0.000543	CcSEcCtD
Felbamate—Hepatitis—Epirubicin—ovarian cancer	0.000172	0.000542	CcSEcCtD
Felbamate—Haemorrhage—Epirubicin—ovarian cancer	0.000172	0.000542	CcSEcCtD
Felbamate—Pharyngitis—Epirubicin—ovarian cancer	0.000171	0.000538	CcSEcCtD
Felbamate—Sweating—Doxorubicin—ovarian cancer	0.00017	0.000536	CcSEcCtD
Felbamate—Urticaria—Paclitaxel—ovarian cancer	0.00017	0.000535	CcSEcCtD
Felbamate—Hypotension—Docetaxel—ovarian cancer	0.000169	0.000534	CcSEcCtD
Felbamate—Haematuria—Doxorubicin—ovarian cancer	0.000169	0.000533	CcSEcCtD
Felbamate—Body temperature increased—Paclitaxel—ovarian cancer	0.000169	0.000533	CcSEcCtD
Felbamate—Abdominal pain—Paclitaxel—ovarian cancer	0.000169	0.000533	CcSEcCtD
Felbamate—Epistaxis—Doxorubicin—ovarian cancer	0.000167	0.000527	CcSEcCtD
Felbamate—Sinusitis—Doxorubicin—ovarian cancer	0.000166	0.000524	CcSEcCtD
Felbamate—Visual impairment—Epirubicin—ovarian cancer	0.000166	0.000523	CcSEcCtD
Felbamate—Agranulocytosis—Doxorubicin—ovarian cancer	0.000165	0.000522	CcSEcCtD
Felbamate—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000165	0.000521	CcSEcCtD
Felbamate—Insomnia—Docetaxel—ovarian cancer	0.000164	0.000517	CcSEcCtD
Felbamate—Paraesthesia—Docetaxel—ovarian cancer	0.000163	0.000513	CcSEcCtD
Felbamate—Erythema multiforme—Epirubicin—ovarian cancer	0.000163	0.000513	CcSEcCtD
Felbamate—Bradycardia—Doxorubicin—ovarian cancer	0.000162	0.000511	CcSEcCtD
Felbamate—Dyspnoea—Docetaxel—ovarian cancer	0.000162	0.000509	CcSEcCtD
Felbamate—Somnolence—Docetaxel—ovarian cancer	0.000161	0.000508	CcSEcCtD
Felbamate—GRIN2B—Transmission across Chemical Synapses—NSF—ovarian cancer	0.000161	0.017	CbGpPWpGaD
Felbamate—CYP2E1—Tamoxifen metabolism—CYP1B1—ovarian cancer	0.00016	0.0169	CbGpPWpGaD
Felbamate—Haemoglobin—Doxorubicin—ovarian cancer	0.00016	0.000504	CcSEcCtD
Felbamate—Flushing—Epirubicin—ovarian cancer	0.00016	0.000503	CcSEcCtD
Felbamate—Rhinitis—Doxorubicin—ovarian cancer	0.00016	0.000503	CcSEcCtD
Felbamate—Dyspepsia—Docetaxel—ovarian cancer	0.00016	0.000503	CcSEcCtD
Felbamate—Hepatitis—Doxorubicin—ovarian cancer	0.000159	0.000502	CcSEcCtD
Felbamate—Haemorrhage—Doxorubicin—ovarian cancer	0.000159	0.000502	CcSEcCtD
Felbamate—Pharyngitis—Doxorubicin—ovarian cancer	0.000158	0.000498	CcSEcCtD
Felbamate—Decreased appetite—Docetaxel—ovarian cancer	0.000158	0.000497	CcSEcCtD
Felbamate—Fatigue—Docetaxel—ovarian cancer	0.000156	0.000493	CcSEcCtD
Felbamate—Constipation—Docetaxel—ovarian cancer	0.000155	0.000489	CcSEcCtD
Felbamate—Pain—Docetaxel—ovarian cancer	0.000155	0.000489	CcSEcCtD
Felbamate—Chills—Epirubicin—ovarian cancer	0.000154	0.000487	CcSEcCtD
Felbamate—Visual impairment—Doxorubicin—ovarian cancer	0.000153	0.000484	CcSEcCtD
Felbamate—Asthenia—Paclitaxel—ovarian cancer	0.000153	0.000484	CcSEcCtD
Felbamate—Alopecia—Epirubicin—ovarian cancer	0.000152	0.000479	CcSEcCtD
Felbamate—Pruritus—Paclitaxel—ovarian cancer	0.000151	0.000477	CcSEcCtD
Felbamate—Erythema multiforme—Doxorubicin—ovarian cancer	0.000151	0.000475	CcSEcCtD
Felbamate—Feeling abnormal—Docetaxel—ovarian cancer	0.000149	0.000471	CcSEcCtD
Felbamate—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000148	0.000467	CcSEcCtD
Felbamate—Flushing—Doxorubicin—ovarian cancer	0.000148	0.000466	CcSEcCtD
Felbamate—CYP3A4—Liver X Receptor Pathway—FASN—ovarian cancer	0.000148	0.0156	CbGpPWpGaD
Felbamate—Flatulence—Epirubicin—ovarian cancer	0.000148	0.000465	CcSEcCtD
Felbamate—Tension—Epirubicin—ovarian cancer	0.000147	0.000463	CcSEcCtD
Felbamate—Dysgeusia—Epirubicin—ovarian cancer	0.000147	0.000462	CcSEcCtD
Felbamate—Diarrhoea—Paclitaxel—ovarian cancer	0.000146	0.000461	CcSEcCtD
Felbamate—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—ovarian cancer	0.000146	0.0155	CbGpPWpGaD
Felbamate—Nervousness—Epirubicin—ovarian cancer	0.000145	0.000459	CcSEcCtD
Felbamate—GRIN2A—Neuronal System—NSF—ovarian cancer	0.000145	0.0154	CbGpPWpGaD
Felbamate—Abdominal pain—Docetaxel—ovarian cancer	0.000143	0.000452	CcSEcCtD
Felbamate—Body temperature increased—Docetaxel—ovarian cancer	0.000143	0.000452	CcSEcCtD
Felbamate—Chills—Doxorubicin—ovarian cancer	0.000143	0.00045	CcSEcCtD
Felbamate—Dizziness—Paclitaxel—ovarian cancer	0.000141	0.000446	CcSEcCtD
Felbamate—Alopecia—Doxorubicin—ovarian cancer	0.000141	0.000443	CcSEcCtD
Felbamate—Ill-defined disorder—Epirubicin—ovarian cancer	0.000139	0.000438	CcSEcCtD
Felbamate—Anaemia—Epirubicin—ovarian cancer	0.000138	0.000436	CcSEcCtD
Felbamate—Agitation—Epirubicin—ovarian cancer	0.000138	0.000434	CcSEcCtD
Felbamate—Flatulence—Doxorubicin—ovarian cancer	0.000137	0.00043	CcSEcCtD
Felbamate—Tension—Doxorubicin—ovarian cancer	0.000136	0.000429	CcSEcCtD
Felbamate—Vomiting—Paclitaxel—ovarian cancer	0.000136	0.000429	CcSEcCtD
Felbamate—Dysgeusia—Doxorubicin—ovarian cancer	0.000136	0.000428	CcSEcCtD
Felbamate—GRIN2A—Ras activation uopn Ca2+ infux through NMDA receptor—HRAS—ovarian cancer	0.000135	0.0143	CbGpPWpGaD
Felbamate—Malaise—Epirubicin—ovarian cancer	0.000135	0.000426	CcSEcCtD
Felbamate—Rash—Paclitaxel—ovarian cancer	0.000135	0.000425	CcSEcCtD
Felbamate—Dermatitis—Paclitaxel—ovarian cancer	0.000135	0.000425	CcSEcCtD
Felbamate—Nervousness—Doxorubicin—ovarian cancer	0.000135	0.000424	CcSEcCtD
Felbamate—Leukopenia—Epirubicin—ovarian cancer	0.000134	0.000423	CcSEcCtD
Felbamate—Headache—Paclitaxel—ovarian cancer	0.000134	0.000422	CcSEcCtD
Felbamate—CYP3A4—Codeine and Morphine Metabolism—ABCB1—ovarian cancer	0.000132	0.014	CbGpPWpGaD
Felbamate—Palpitations—Epirubicin—ovarian cancer	0.000132	0.000417	CcSEcCtD
Felbamate—Cough—Epirubicin—ovarian cancer	0.000131	0.000412	CcSEcCtD
Felbamate—Asthenia—Docetaxel—ovarian cancer	0.00013	0.00041	CcSEcCtD
Felbamate—Hypertension—Epirubicin—ovarian cancer	0.000129	0.000408	CcSEcCtD
Felbamate—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000129	0.000405	CcSEcCtD
Felbamate—Pruritus—Docetaxel—ovarian cancer	0.000128	0.000404	CcSEcCtD
Felbamate—Anaemia—Doxorubicin—ovarian cancer	0.000128	0.000404	CcSEcCtD
Felbamate—Chest pain—Epirubicin—ovarian cancer	0.000128	0.000402	CcSEcCtD
Felbamate—Arthralgia—Epirubicin—ovarian cancer	0.000128	0.000402	CcSEcCtD
Felbamate—Myalgia—Epirubicin—ovarian cancer	0.000128	0.000402	CcSEcCtD
Felbamate—Agitation—Doxorubicin—ovarian cancer	0.000127	0.000401	CcSEcCtD
Felbamate—Anxiety—Epirubicin—ovarian cancer	0.000127	0.000401	CcSEcCtD
Felbamate—Nausea—Paclitaxel—ovarian cancer	0.000127	0.0004	CcSEcCtD
Felbamate—GRIN2B—ErbB4 signaling events—ERBB2—ovarian cancer	0.000127	0.0134	CbGpPWpGaD
Felbamate—Discomfort—Epirubicin—ovarian cancer	0.000126	0.000397	CcSEcCtD
Felbamate—GRIN2B—ErbB4 signaling events—PIK3CB—ovarian cancer	0.000125	0.0132	CbGpPWpGaD
Felbamate—Malaise—Doxorubicin—ovarian cancer	0.000125	0.000394	CcSEcCtD
Felbamate—Dry mouth—Epirubicin—ovarian cancer	0.000125	0.000393	CcSEcCtD
Felbamate—Leukopenia—Doxorubicin—ovarian cancer	0.000124	0.000391	CcSEcCtD
Felbamate—Diarrhoea—Docetaxel—ovarian cancer	0.000124	0.000391	CcSEcCtD
Felbamate—CYP2C19—Tamoxifen metabolism—CYP1B1—ovarian cancer	0.000124	0.0131	CbGpPWpGaD
Felbamate—GRIN2B—Neuronal System—NSF—ovarian cancer	0.000123	0.0131	CbGpPWpGaD
Felbamate—Confusional state—Epirubicin—ovarian cancer	0.000123	0.000389	CcSEcCtD
Felbamate—Palpitations—Doxorubicin—ovarian cancer	0.000122	0.000386	CcSEcCtD
Felbamate—Anaphylactic shock—Epirubicin—ovarian cancer	0.000122	0.000385	CcSEcCtD
Felbamate—Oedema—Epirubicin—ovarian cancer	0.000122	0.000385	CcSEcCtD
Felbamate—Infection—Epirubicin—ovarian cancer	0.000121	0.000383	CcSEcCtD
Felbamate—Cough—Doxorubicin—ovarian cancer	0.000121	0.000381	CcSEcCtD
Felbamate—GRIN2A—CREB phosphorylation through the activation of Ras—MAPK1—ovarian cancer	0.00012	0.0127	CbGpPWpGaD
Felbamate—Dizziness—Docetaxel—ovarian cancer	0.00012	0.000378	CcSEcCtD
Felbamate—Thrombocytopenia—Epirubicin—ovarian cancer	0.00012	0.000377	CcSEcCtD
Felbamate—Hypertension—Doxorubicin—ovarian cancer	0.00012	0.000377	CcSEcCtD
Felbamate—Tachycardia—Epirubicin—ovarian cancer	0.000119	0.000376	CcSEcCtD
Felbamate—Hyperhidrosis—Epirubicin—ovarian cancer	0.000118	0.000373	CcSEcCtD
Felbamate—Chest pain—Doxorubicin—ovarian cancer	0.000118	0.000372	CcSEcCtD
Felbamate—Arthralgia—Doxorubicin—ovarian cancer	0.000118	0.000372	CcSEcCtD
Felbamate—Myalgia—Doxorubicin—ovarian cancer	0.000118	0.000372	CcSEcCtD
Felbamate—Anxiety—Doxorubicin—ovarian cancer	0.000118	0.000371	CcSEcCtD
Felbamate—GRIN2A—Hypothetical Network for Drug Addiction—MAPK3—ovarian cancer	0.000117	0.0123	CbGpPWpGaD
Felbamate—Discomfort—Doxorubicin—ovarian cancer	0.000117	0.000367	CcSEcCtD
Felbamate—Anorexia—Epirubicin—ovarian cancer	0.000117	0.000367	CcSEcCtD
Felbamate—Dry mouth—Doxorubicin—ovarian cancer	0.000115	0.000364	CcSEcCtD
Felbamate—Vomiting—Docetaxel—ovarian cancer	0.000115	0.000363	CcSEcCtD
Felbamate—GRIN2B—Ras activation uopn Ca2+ infux through NMDA receptor—HRAS—ovarian cancer	0.000115	0.0122	CbGpPWpGaD
Felbamate—Rash—Docetaxel—ovarian cancer	0.000114	0.00036	CcSEcCtD
Felbamate—Hypotension—Epirubicin—ovarian cancer	0.000114	0.00036	CcSEcCtD
Felbamate—Dermatitis—Docetaxel—ovarian cancer	0.000114	0.00036	CcSEcCtD
Felbamate—Confusional state—Doxorubicin—ovarian cancer	0.000114	0.00036	CcSEcCtD
Felbamate—Headache—Docetaxel—ovarian cancer	0.000114	0.000358	CcSEcCtD
Felbamate—Oedema—Doxorubicin—ovarian cancer	0.000113	0.000357	CcSEcCtD
Felbamate—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000113	0.000357	CcSEcCtD
Felbamate—Infection—Doxorubicin—ovarian cancer	0.000112	0.000354	CcSEcCtD
Felbamate—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000111	0.000351	CcSEcCtD
Felbamate—GRIN2B—BDNF signaling pathway—IKBKG—ovarian cancer	0.000111	0.0118	CbGpPWpGaD
Felbamate—GRIN2A—Hypothetical Network for Drug Addiction—MAPK1—ovarian cancer	0.000111	0.0117	CbGpPWpGaD
Felbamate—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000111	0.000349	CcSEcCtD
Felbamate—Insomnia—Epirubicin—ovarian cancer	0.000111	0.000349	CcSEcCtD
Felbamate—Tachycardia—Doxorubicin—ovarian cancer	0.00011	0.000348	CcSEcCtD
Felbamate—Paraesthesia—Epirubicin—ovarian cancer	0.00011	0.000346	CcSEcCtD
Felbamate—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000109	0.000345	CcSEcCtD
Felbamate—Dyspnoea—Epirubicin—ovarian cancer	0.000109	0.000344	CcSEcCtD
Felbamate—Somnolence—Epirubicin—ovarian cancer	0.000109	0.000343	CcSEcCtD
Felbamate—Anorexia—Doxorubicin—ovarian cancer	0.000108	0.00034	CcSEcCtD
Felbamate—Nausea—Docetaxel—ovarian cancer	0.000108	0.000339	CcSEcCtD
Felbamate—Dyspepsia—Epirubicin—ovarian cancer	0.000108	0.000339	CcSEcCtD
Felbamate—GRIN2A—Reelin signaling pathway—PIK3CA—ovarian cancer	0.000107	0.0113	CbGpPWpGaD
Felbamate—Decreased appetite—Epirubicin—ovarian cancer	0.000106	0.000335	CcSEcCtD
Felbamate—Hypotension—Doxorubicin—ovarian cancer	0.000106	0.000333	CcSEcCtD
Felbamate—Fatigue—Epirubicin—ovarian cancer	0.000105	0.000332	CcSEcCtD
Felbamate—Pain—Epirubicin—ovarian cancer	0.000105	0.00033	CcSEcCtD
Felbamate—Constipation—Epirubicin—ovarian cancer	0.000105	0.00033	CcSEcCtD
Felbamate—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000103	0.000325	CcSEcCtD
Felbamate—Insomnia—Doxorubicin—ovarian cancer	0.000102	0.000322	CcSEcCtD
Felbamate—GRIN2B—CREB phosphorylation through the activation of Ras—MAPK1—ovarian cancer	0.000102	0.0108	CbGpPWpGaD
Felbamate—Paraesthesia—Doxorubicin—ovarian cancer	0.000102	0.00032	CcSEcCtD
Felbamate—Dyspnoea—Doxorubicin—ovarian cancer	0.000101	0.000318	CcSEcCtD
Felbamate—Feeling abnormal—Epirubicin—ovarian cancer	0.000101	0.000318	CcSEcCtD
Felbamate—Somnolence—Doxorubicin—ovarian cancer	0.000101	0.000317	CcSEcCtD
Felbamate—Gastrointestinal pain—Epirubicin—ovarian cancer	9.99e-05	0.000315	CcSEcCtD
Felbamate—Dyspepsia—Doxorubicin—ovarian cancer	9.96e-05	0.000314	CcSEcCtD
Felbamate—GRIN2B—Hypothetical Network for Drug Addiction—MAPK3—ovarian cancer	9.92e-05	0.0105	CbGpPWpGaD
Felbamate—GRIN2A—Post NMDA receptor activation events—MAPK1—ovarian cancer	9.88e-05	0.0105	CbGpPWpGaD
Felbamate—Decreased appetite—Doxorubicin—ovarian cancer	9.83e-05	0.00031	CcSEcCtD
Felbamate—Fatigue—Doxorubicin—ovarian cancer	9.75e-05	0.000307	CcSEcCtD
Felbamate—Urticaria—Epirubicin—ovarian cancer	9.71e-05	0.000306	CcSEcCtD
Felbamate—Pain—Doxorubicin—ovarian cancer	9.67e-05	0.000305	CcSEcCtD
Felbamate—Constipation—Doxorubicin—ovarian cancer	9.67e-05	0.000305	CcSEcCtD
Felbamate—Body temperature increased—Epirubicin—ovarian cancer	9.66e-05	0.000305	CcSEcCtD
Felbamate—Abdominal pain—Epirubicin—ovarian cancer	9.66e-05	0.000305	CcSEcCtD
Felbamate—GRIN2A—CREB phosphorylation through the activation of Ras—HRAS—ovarian cancer	9.64e-05	0.0102	CbGpPWpGaD
Felbamate—CYP2C19—Melatonin metabolism and effects—CYP1B1—ovarian cancer	9.54e-05	0.0101	CbGpPWpGaD
Felbamate—GRIN2B—Hypothetical Network for Drug Addiction—MAPK1—ovarian cancer	9.44e-05	0.00999	CbGpPWpGaD
Felbamate—Feeling abnormal—Doxorubicin—ovarian cancer	9.32e-05	0.000294	CcSEcCtD
Felbamate—Gastrointestinal pain—Doxorubicin—ovarian cancer	9.25e-05	0.000292	CcSEcCtD
Felbamate—GRIN2B—ErbB4 signaling events—MAPK3—ovarian cancer	9.23e-05	0.00977	CbGpPWpGaD
Felbamate—GRIN2B—Reelin signaling pathway—PIK3CA—ovarian cancer	9.11e-05	0.00964	CbGpPWpGaD
Felbamate—GRIN2A—Activation of NMDA receptor upon glutamate binding and postsynaptic events—MAPK1—ovarian cancer	9.1e-05	0.00963	CbGpPWpGaD
Felbamate—Urticaria—Doxorubicin—ovarian cancer	8.98e-05	0.000283	CcSEcCtD
Felbamate—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	8.97e-05	0.00949	CbGpPWpGaD
Felbamate—Body temperature increased—Doxorubicin—ovarian cancer	8.94e-05	0.000282	CcSEcCtD
Felbamate—Abdominal pain—Doxorubicin—ovarian cancer	8.94e-05	0.000282	CcSEcCtD
Felbamate—GRIN2B—ErbB4 signaling events—MAPK1—ovarian cancer	8.79e-05	0.0093	CbGpPWpGaD
Felbamate—Asthenia—Epirubicin—ovarian cancer	8.77e-05	0.000276	CcSEcCtD
Felbamate—GRIN2A—Reelin signaling pathway—AKT1—ovarian cancer	8.76e-05	0.00926	CbGpPWpGaD
Felbamate—Pruritus—Epirubicin—ovarian cancer	8.65e-05	0.000273	CcSEcCtD
Felbamate—CYP2E1—Tryptophan metabolism—CYP1B1—ovarian cancer	8.55e-05	0.00904	CbGpPWpGaD
Felbamate—GRIN2B—Post NMDA receptor activation events—MAPK1—ovarian cancer	8.4e-05	0.00889	CbGpPWpGaD
Felbamate—CYP3A4—Estrogen metabolism—CYP1B1—ovarian cancer	8.4e-05	0.00889	CbGpPWpGaD
Felbamate—Diarrhoea—Epirubicin—ovarian cancer	8.36e-05	0.000264	CcSEcCtD
Felbamate—GRIN2B—CREB phosphorylation through the activation of Ras—HRAS—ovarian cancer	8.2e-05	0.00867	CbGpPWpGaD
Felbamate—Asthenia—Doxorubicin—ovarian cancer	8.11e-05	0.000256	CcSEcCtD
Felbamate—Dizziness—Epirubicin—ovarian cancer	8.08e-05	0.000255	CcSEcCtD
Felbamate—Pruritus—Doxorubicin—ovarian cancer	8e-05	0.000252	CcSEcCtD
Felbamate—GRIN2A—Post NMDA receptor activation events—HRAS—ovarian cancer	7.94e-05	0.00839	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—NR5A1—ovarian cancer	7.81e-05	0.00826	CbGpPWpGaD
Felbamate—Vomiting—Epirubicin—ovarian cancer	7.77e-05	0.000245	CcSEcCtD
Felbamate—GRIN2B—Activation of NMDA receptor upon glutamate binding and postsynaptic events—MAPK1—ovarian cancer	7.74e-05	0.00819	CbGpPWpGaD
Felbamate—Diarrhoea—Doxorubicin—ovarian cancer	7.74e-05	0.000244	CcSEcCtD
Felbamate—Rash—Epirubicin—ovarian cancer	7.71e-05	0.000243	CcSEcCtD
Felbamate—Dermatitis—Epirubicin—ovarian cancer	7.7e-05	0.000243	CcSEcCtD
Felbamate—Headache—Epirubicin—ovarian cancer	7.66e-05	0.000241	CcSEcCtD
Felbamate—GRIN2B—ErbB4 signaling events—PIK3CA—ovarian cancer	7.62e-05	0.00807	CbGpPWpGaD
Felbamate—Dizziness—Doxorubicin—ovarian cancer	7.48e-05	0.000236	CcSEcCtD
Felbamate—GRIN2B—Reelin signaling pathway—AKT1—ovarian cancer	7.45e-05	0.00788	CbGpPWpGaD
Felbamate—CYP3A4—Tamoxifen metabolism—CYP1B1—ovarian cancer	7.43e-05	0.00786	CbGpPWpGaD
Felbamate—GRIN2A—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—ovarian cancer	7.31e-05	0.00773	CbGpPWpGaD
Felbamate—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—ovarian cancer	7.26e-05	0.00768	CbGpPWpGaD
Felbamate—Nausea—Epirubicin—ovarian cancer	7.26e-05	0.000229	CcSEcCtD
Felbamate—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—ovarian cancer	7.24e-05	0.00766	CbGpPWpGaD
Felbamate—Vomiting—Doxorubicin—ovarian cancer	7.19e-05	0.000227	CcSEcCtD
Felbamate—Rash—Doxorubicin—ovarian cancer	7.13e-05	0.000225	CcSEcCtD
Felbamate—Dermatitis—Doxorubicin—ovarian cancer	7.12e-05	0.000225	CcSEcCtD
Felbamate—Headache—Doxorubicin—ovarian cancer	7.08e-05	0.000223	CcSEcCtD
Felbamate—GRIN2A—Alzheimers Disease—CASP3—ovarian cancer	7.05e-05	0.00746	CbGpPWpGaD
Felbamate—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	6.91e-05	0.00731	CbGpPWpGaD
Felbamate—CYP2E1—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	6.82e-05	0.00722	CbGpPWpGaD
Felbamate—GRIN2B—Post NMDA receptor activation events—HRAS—ovarian cancer	6.75e-05	0.00714	CbGpPWpGaD
Felbamate—Nausea—Doxorubicin—ovarian cancer	6.72e-05	0.000212	CcSEcCtD
Felbamate—GRIN2B—EPH-Ephrin signaling—MMP2—ovarian cancer	6.56e-05	0.00694	CbGpPWpGaD
Felbamate—GRIN2B—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—ovarian cancer	6.22e-05	0.00658	CbGpPWpGaD
Felbamate—GRIN2B—EPHB-mediated forward signaling—HRAS—ovarian cancer	6.22e-05	0.00658	CbGpPWpGaD
Felbamate—CYP2C19—Arachidonic acid metabolism—CYP1B1—ovarian cancer	6.17e-05	0.00653	CbGpPWpGaD
Felbamate—CYP3A4—Irinotecan Pathway—APC—ovarian cancer	6.1e-05	0.00645	CbGpPWpGaD
Felbamate—GRIN2B—Alzheimers Disease—CASP3—ovarian cancer	6e-05	0.00634	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—HNF1B—ovarian cancer	5.76e-05	0.00609	CbGpPWpGaD
Felbamate—GRIN2A—Alzheimers Disease—MAPK3—ovarian cancer	5.66e-05	0.00599	CbGpPWpGaD
Felbamate—CYP2E1—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	5.6e-05	0.00593	CbGpPWpGaD
Felbamate—GRIN2A—Alzheimers Disease—MAPK1—ovarian cancer	5.39e-05	0.0057	CbGpPWpGaD
Felbamate—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	5.33e-05	0.00564	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—APC—ovarian cancer	5.26e-05	0.00557	CbGpPWpGaD
Felbamate—CYP2C19—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	5.26e-05	0.00557	CbGpPWpGaD
Felbamate—GRIN2B—EPH-Ephrin signaling—MMP9—ovarian cancer	4.93e-05	0.00522	CbGpPWpGaD
Felbamate—GRIN2B—Alzheimers Disease—MAPK3—ovarian cancer	4.81e-05	0.00509	CbGpPWpGaD
Felbamate—GRIN2B—Alzheimers Disease—MAPK1—ovarian cancer	4.58e-05	0.00485	CbGpPWpGaD
Felbamate—GRIN2A—Alzheimers Disease—TP53—ovarian cancer	4.52e-05	0.00478	CbGpPWpGaD
Felbamate—GRIN2B—EPH-Ephrin signaling—VEGFA—ovarian cancer	4.43e-05	0.00469	CbGpPWpGaD
Felbamate—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—ovarian cancer	4.37e-05	0.00462	CbGpPWpGaD
Felbamate—CYP2C19—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	4.32e-05	0.00457	CbGpPWpGaD
Felbamate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	4.16e-05	0.0044	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—MTOR—ovarian cancer	4.03e-05	0.00427	CbGpPWpGaD
Felbamate—CYP3A4—Tryptophan metabolism—CYP1B1—ovarian cancer	3.97e-05	0.0042	CbGpPWpGaD
Felbamate—GRIN2B—Alzheimers Disease—TP53—ovarian cancer	3.85e-05	0.00407	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—CASP3—ovarian cancer	3.71e-05	0.00393	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—CTNNB1—ovarian cancer	3.58e-05	0.00378	CbGpPWpGaD
Felbamate—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	3.41e-05	0.00361	CbGpPWpGaD
Felbamate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	3.21e-05	0.00339	CbGpPWpGaD
Felbamate—GRIN2B—EPH-Ephrin signaling—HRAS—ovarian cancer	3.2e-05	0.00339	CbGpPWpGaD
Felbamate—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	3.16e-05	0.00335	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—STAT3—ovarian cancer	3.12e-05	0.0033	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—MAPK3—ovarian cancer	2.98e-05	0.00315	CbGpPWpGaD
Felbamate—CYP2E1—Biological oxidations—CYP1B1—ovarian cancer	2.98e-05	0.00315	CbGpPWpGaD
Felbamate—CYP2E1—Metapathway biotransformation—CYP1B1—ovarian cancer	2.94e-05	0.00311	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—MET—ovarian cancer	2.92e-05	0.00309	CbGpPWpGaD
Felbamate—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	2.9e-05	0.00307	CbGpPWpGaD
Felbamate—CYP2E1—Vitamin A and Carotenoid Metabolism—MAPK1—ovarian cancer	2.88e-05	0.00305	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—IL6ST—ovarian cancer	2.86e-05	0.00303	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—MAPK1—ovarian cancer	2.83e-05	0.003	CbGpPWpGaD
Felbamate—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	2.74e-05	0.0029	CbGpPWpGaD
Felbamate—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	2.6e-05	0.00275	CbGpPWpGaD
Felbamate—GRIN2A—Transmission across Chemical Synapses—MAPK1—ovarian cancer	2.56e-05	0.00271	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—MMP2—ovarian cancer	2.44e-05	0.00258	CbGpPWpGaD
Felbamate—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	2.33e-05	0.00246	CbGpPWpGaD
Felbamate—CYP2C19—Biological oxidations—CYP1B1—ovarian cancer	2.3e-05	0.00243	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—HRAS—ovarian cancer	2.28e-05	0.00241	CbGpPWpGaD
Felbamate—CYP2C19—Metapathway biotransformation—CYP1B1—ovarian cancer	2.26e-05	0.0024	CbGpPWpGaD
Felbamate—GRIN2B—Transmission across Chemical Synapses—MAPK1—ovarian cancer	2.18e-05	0.00231	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—ERBB2—ovarian cancer	2.14e-05	0.00226	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—MET—ovarian cancer	2.09e-05	0.00221	CbGpPWpGaD
Felbamate—GRIN2A—Transmission across Chemical Synapses—HRAS—ovarian cancer	2.06e-05	0.00218	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—IL6ST—ovarian cancer	2.04e-05	0.00216	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—AKT1—ovarian cancer	2.01e-05	0.00213	CbGpPWpGaD
Felbamate—GRIN2A—Neuronal System—MAPK1—ovarian cancer	1.96e-05	0.00208	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—MMP9—ovarian cancer	1.83e-05	0.00194	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—NME2—ovarian cancer	1.81e-05	0.00192	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	1.77e-05	0.00187	CbGpPWpGaD
Felbamate—GRIN2B—Transmission across Chemical Synapses—HRAS—ovarian cancer	1.75e-05	0.00185	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—MMP2—ovarian cancer	1.74e-05	0.00184	CbGpPWpGaD
Felbamate—GRIN2B—Neuronal System—MAPK1—ovarian cancer	1.67e-05	0.00177	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—VEGFA—ovarian cancer	1.65e-05	0.00174	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—NRAS—ovarian cancer	1.63e-05	0.00172	CbGpPWpGaD
Felbamate—GRIN2A—Neuronal System—HRAS—ovarian cancer	1.58e-05	0.00167	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—MAPK3—ovarian cancer	1.56e-05	0.00165	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—ERBB2—ovarian cancer	1.52e-05	0.00161	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—MAPK1—ovarian cancer	1.48e-05	0.00157	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—EGFR—ovarian cancer	1.48e-05	0.00157	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—NME2—ovarian cancer	1.4e-05	0.00148	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—KRAS—ovarian cancer	1.4e-05	0.00148	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	1.38e-05	0.00146	CbGpPWpGaD
Felbamate—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	1.36e-05	0.00144	CbGpPWpGaD
Felbamate—GRIN2B—Neuronal System—HRAS—ovarian cancer	1.34e-05	0.00142	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—CTNNB1—ovarian cancer	1.33e-05	0.00141	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—MMP9—ovarian cancer	1.31e-05	0.00138	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—HRAS—ovarian cancer	1.19e-05	0.00126	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	1.19e-05	0.00126	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—VEGFA—ovarian cancer	1.17e-05	0.00124	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—CYTB—ovarian cancer	1.17e-05	0.00124	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—STAT3—ovarian cancer	1.16e-05	0.00123	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—NRAS—ovarian cancer	1.16e-05	0.00123	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—IL6—ovarian cancer	1.14e-05	0.0012	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—MAPK3—ovarian cancer	1.11e-05	0.00118	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—MAPK1—ovarian cancer	1.06e-05	0.00112	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—EGFR—ovarian cancer	1.06e-05	0.00112	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PPP1CC—ovarian cancer	1.02e-05	0.00108	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—BRIP1—ovarian cancer	1.02e-05	0.00108	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—KRAS—ovarian cancer	9.98e-06	0.00106	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	9.68e-06	0.00102	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CYTB—ovarian cancer	9.02e-06	0.000954	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	8.82e-06	0.000933	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—HRAS—ovarian cancer	8.49e-06	0.000898	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—NME2—ovarian cancer	8.42e-06	0.000891	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—IL6—ovarian cancer	8.12e-06	0.000859	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PPP1CC—ovarian cancer	7.89e-06	0.000834	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—BRIP1—ovarian cancer	7.89e-06	0.000834	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—AKT1—ovarian cancer	7.49e-06	0.000793	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—YAP1—ovarian cancer	6.86e-06	0.000725	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	5.75e-06	0.000608	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—FASN—ovarian cancer	5.59e-06	0.000591	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—SLC5A5—ovarian cancer	5.5e-06	0.000582	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CYTB—ovarian cancer	5.43e-06	0.000574	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—SLC2A1—ovarian cancer	5.31e-06	0.000562	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—YAP1—ovarian cancer	5.29e-06	0.00056	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	5.23e-06	0.000554	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—CYP1B1—ovarian cancer	5.09e-06	0.000538	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PPP1CC—ovarian cancer	4.74e-06	0.000502	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—BRIP1—ovarian cancer	4.74e-06	0.000502	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	4.6e-06	0.000487	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PPP2R1A—ovarian cancer	4.51e-06	0.000478	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—FASN—ovarian cancer	4.31e-06	0.000456	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—SLC5A5—ovarian cancer	4.24e-06	0.000449	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—ABCB1—ovarian cancer	4.19e-06	0.000443	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—TYMS—ovarian cancer	4.12e-06	0.000436	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—SLC2A1—ovarian cancer	4.1e-06	0.000433	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	4.01e-06	0.000424	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CYP1B1—ovarian cancer	3.93e-06	0.000415	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PPP2R1A—ovarian cancer	3.48e-06	0.000368	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	3.47e-06	0.000367	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—CAV1—ovarian cancer	3.32e-06	0.000351	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—ABCB1—ovarian cancer	3.23e-06	0.000342	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—YAP1—ovarian cancer	3.18e-06	0.000336	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—TYMS—ovarian cancer	3.18e-06	0.000336	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PIK3CG—ovarian cancer	3.02e-06	0.00032	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PIK3CD—ovarian cancer	2.66e-06	0.000281	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—FASN—ovarian cancer	2.59e-06	0.000274	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CAV1—ovarian cancer	2.56e-06	0.000271	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—SLC5A5—ovarian cancer	2.55e-06	0.00027	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—SLC2A1—ovarian cancer	2.46e-06	0.000261	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.45e-06	0.000259	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CYP1B1—ovarian cancer	2.36e-06	0.00025	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PIK3CG—ovarian cancer	2.33e-06	0.000247	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PIK3CB—ovarian cancer	2.32e-06	0.000245	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	2.09e-06	0.000222	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PIK3CD—ovarian cancer	2.05e-06	0.000217	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PTEN—ovarian cancer	2e-06	0.000212	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—ABCB1—ovarian cancer	1.94e-06	0.000206	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—TYMS—ovarian cancer	1.91e-06	0.000202	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PIK3CB—ovarian cancer	1.79e-06	0.000189	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PTEN—ovarian cancer	1.54e-06	0.000163	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CAV1—ovarian cancer	1.54e-06	0.000163	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PIK3CA—ovarian cancer	1.41e-06	0.000149	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PIK3CG—ovarian cancer	1.4e-06	0.000148	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PIK3CD—ovarian cancer	1.23e-06	0.00013	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—AKT1—ovarian cancer	1.15e-06	0.000122	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PIK3CA—ovarian cancer	1.09e-06	0.000115	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PIK3CB—ovarian cancer	1.07e-06	0.000114	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PTEN—ovarian cancer	9.28e-07	9.82e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—AKT1—ovarian cancer	8.9e-07	9.41e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PIK3CA—ovarian cancer	6.55e-07	6.93e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—AKT1—ovarian cancer	5.35e-07	5.66e-05	CbGpPWpGaD
